NewAmsterdam PharmaNAMS
那斯達克 · USD
36.90
+0.73
(+2.02%)
盤中 12/13 02:35 (UTC+8)
12/13 02:35 (UTC+8)
NewAmsterdam PharmaNAMS
36.90
+0.73
(+2.02%)
財務數據
損益表
- 0.02
- 0.03
- 0.01
- 0.01
- 0.02
- 0.29
- 0.13
- 0.03
- 0.19
- 0.00
- -80.10
- 71.29
- -72.70
- 74.47
- 62.67
- 1177.36
- -56.13
- -76.68
- 542.88
- -98.18
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 348 | 19,145 | 2,978 | 12,772 | 29,111 | 2,279 | 1,401 | 803 | 2,941 | 1,717 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 348 | - | - | - | 29,111 | - | 1,401 | 803 | 2,941 | 1,717 |
營業費用 | 55,491 | 54,780 | 71,903 | 59,206 | 54,114 | 54,854 | 56,883 | 49,998 | 51,224 | 40,716 |
研發費用 | 30,971 | 27,516 | 44,751 | 34,895 | 35,702 | 38,379 | 42,430 | 41,292 | 43,371 | 34,341 |
推銷及管理費用 | 24,520 | 27,264 | 27,152 | 24,311 | 18,412 | 16,475 | 14,453 | 8,706 | 7,853 | 6,375 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -55,143 | -35,635 | -68,925 | -46,434 | -25,003 | -52,575 | -55,482 | -49,195 | -48,283 | -38,999 |
其他收入及費用 | - | - | - | - | - | - | - | - | - | - |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -72,005 | -17,364 | -39,527 | -92,177 | -16,648 | -39,007 | -93,767 | -49,468 | -47,133 | -38,291 |
所得稅 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 27 | 0 | 0 |
稅後純益 | -72,005 | -17,364 | -39,527 | -92,177 | -16,647 | -39,007 | -93,767 | -49,495 | -47,133 | -38,291 |
基本每股稅後盈餘(元) | -0.61 | -0.15 | -0.34 | -0.91 | -0.18 | -0.41 | -1.06 | - | -0.57 | -0.47 |
稀釋每股稅後盈餘(元) | -0.61 | -0.15 | -0.34 | -0.91 | -0.18 | -0.41 | -1.06 | - | -0.57 | -0.47 |
基本平均股數(千股) | 119000.00 | 112509.00 | 116124.00 | 99587.00 | 94754.00 | 94711.00 | 88380.00 | - | 82466.00 | 82064.00 |
稀釋平均股數(千股) | 119000.00 | 112509.00 | 116124.00 | 99587.00 | 94754.00 | 94711.00 | 88380.00 | - | 82466.00 | 82064.00 |
還原基本每股稅後盈餘(元) | -0.61 | -0.15 | -0.34 | -0.91 | -0.18 | -0.41 | -1.06 | - | -0.57 | -0.47 |
還原稀釋每股稅後盈餘(元) | -0.61 | -0.15 | -0.34 | -0.91 | -0.18 | -0.41 | -1.06 | - | -0.57 | -0.47 |
還原基本平均股數(千股) | 119,000 | 112,509 | 116,124 | 99,587 | 94,754 | 94,711 | 88,380 | - | 82,466 | 82,064 |
還原稀釋平均股數(千股) | 119,000 | 112,509 | 116,124 | 99,587 | 94,754 | 94,711 | 88,380 | - | 82,466 | 82,064 |
EBITDA(千元) | -71,941 | -17,319 | -39,475 | -92,126 | -16,620 | -38,988 | -93,752 | -49,455 | -47,119 | -38,278 |